Prothena Corporation plc Stock News

Prothena (PRTA) reported earnings 30 days ago. What's next for the stock?

DUBLIN, Ireland, March 08, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational ther

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Biotech stocks and secondary and initial public offerings were well represented this week

The stock price of Prothena Corporation PLC (NASDAQ: PRTA) increased by 45.54% on Friday, February 12. This is why it happened.

Prothena (PRTA) beats on earnings in the fourth quarter of 2020 and surpasses sales estimates too.

Corvus Pharmaceuticals (NASDAQ: CRVS) shares are trading lower Friday after the company priced its 8.571 million share common stock offering at $3.50 per share. Corvus Pharmaceuticals Inc is a clinica

Prothena Corporation (PRTA) CEO Gene Kinney on Q4 2020 Results - Earnings Call Transcript

Shares of Prothena Corp (NASDAQ:PRTA) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share decreased 42.59% year over year to ($0.77), which were in line with the

DUBLIN, Ireland, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational thera

DUBLIN, Ireland, Feb. 05, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational thera

DUBLIN, Ireland, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational thera

Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The stock price of Prothena Corporation PLC (NASDAQ: PRTA) has increased by over 25% pre-market today as of 6:19 AM ET. This is why it happened.

DUBLIN, Ireland, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA) today announced that following further analyses by the Company and multiple in-depth discussions with the U.S.

DUBLIN, Ireland, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a diverse pipeline of investigation